Internet-based psychodynamic versus cognitive behaviour therapy for adolescents with depression: study protocol for a non-inferiority randomized controlled trial (the ERiCA study).
Adolescents
CBT
Depression
Internet-based treatment
Non-inferiority trial
Psychodynamic
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
29 Jun 2020
29 Jun 2020
Historique:
received:
28
02
2020
accepted:
08
06
2020
entrez:
1
7
2020
pubmed:
1
7
2020
medline:
7
4
2021
Statut:
epublish
Résumé
Adolescent depression is a common mental health problem and there is an urgent need for effective and accessible treatments. Internet-based interventions solve many obstacles for seeking and receiving treatment, thus increasing access to effective treatments. Internet-based cognitive behavioural therapy (ICBT) for adolescent depression has demonstrated efficacy in previous trials. In order to broaden the range of evidence-based treatments for young people, we evaluated a newly developed affect-focused Internet-based psychodynamic treatment (IPDT) in a previous study with promising results. The purpose of the planned study is to evaluate the efficacy of IPDT for adolescent depression in a non-inferiority trial, comparing it to ICBT. The study will employ a parallel randomized non-inferiority design (ratio 1:1; n = 270). Eligible participants are adolescents 15-19 years suffering from depression. The primary hypothesis is that IPDT will be non-inferior to ICBT in reducing depressive symptoms from pre-treatment to end of treatment. Secondary research questions include comparing outcomes of IPDT and ICBT regarding anxiety symptoms, emotion regulation and self-compassion. Additional data will be collected to evaluate cost-effectiveness as well as investigating predictors, moderators and mediators of outcome. In addition, we will examine long-term outcome up to 1 year after end of treatment. Diagnostic interviews with MINI 7.0 will be used to establish primary diagnosis of depression as well as ruling out any exclusion criteria. Both treatments consist of eight modules over 10 weeks, complemented with therapist support through text messages and weekly chat sessions. Primary outcome measure is the Quick Inventory of Depressive Symptomatology in Adolescents Self-Rated (QIDS-A17-SR). Primary outcome will be analysed using data from all participants entering the study using a multilevel growth curve strategy based on the weekly measurements of QIDS-A17-SR. The non-inferiority margin is defined as d = 0.30. This trial will demonstrate whether IPDT is non-inferior to ICBT in the treatment of adolescent depression. The study might therefore broaden the range of evidence-based treatment alternatives for young people struggling with depression. Further analyses of data from this trial may increase our knowledge about "what works for whom" and the pathways of change for two distinct types of interventions. ISRCTN12552584 , Registered on 13 August 2019.
Sections du résumé
BACKGROUND
BACKGROUND
Adolescent depression is a common mental health problem and there is an urgent need for effective and accessible treatments. Internet-based interventions solve many obstacles for seeking and receiving treatment, thus increasing access to effective treatments. Internet-based cognitive behavioural therapy (ICBT) for adolescent depression has demonstrated efficacy in previous trials. In order to broaden the range of evidence-based treatments for young people, we evaluated a newly developed affect-focused Internet-based psychodynamic treatment (IPDT) in a previous study with promising results. The purpose of the planned study is to evaluate the efficacy of IPDT for adolescent depression in a non-inferiority trial, comparing it to ICBT.
METHODS
METHODS
The study will employ a parallel randomized non-inferiority design (ratio 1:1; n = 270). Eligible participants are adolescents 15-19 years suffering from depression. The primary hypothesis is that IPDT will be non-inferior to ICBT in reducing depressive symptoms from pre-treatment to end of treatment. Secondary research questions include comparing outcomes of IPDT and ICBT regarding anxiety symptoms, emotion regulation and self-compassion. Additional data will be collected to evaluate cost-effectiveness as well as investigating predictors, moderators and mediators of outcome. In addition, we will examine long-term outcome up to 1 year after end of treatment. Diagnostic interviews with MINI 7.0 will be used to establish primary diagnosis of depression as well as ruling out any exclusion criteria. Both treatments consist of eight modules over 10 weeks, complemented with therapist support through text messages and weekly chat sessions. Primary outcome measure is the Quick Inventory of Depressive Symptomatology in Adolescents Self-Rated (QIDS-A17-SR). Primary outcome will be analysed using data from all participants entering the study using a multilevel growth curve strategy based on the weekly measurements of QIDS-A17-SR. The non-inferiority margin is defined as d = 0.30.
DISCUSSION
CONCLUSIONS
This trial will demonstrate whether IPDT is non-inferior to ICBT in the treatment of adolescent depression. The study might therefore broaden the range of evidence-based treatment alternatives for young people struggling with depression. Further analyses of data from this trial may increase our knowledge about "what works for whom" and the pathways of change for two distinct types of interventions.
TRIAL REGISTRATION
BACKGROUND
ISRCTN12552584 , Registered on 13 August 2019.
Identifiants
pubmed: 32600400
doi: 10.1186/s13063-020-04491-z
pii: 10.1186/s13063-020-04491-z
pmc: PMC7322832
doi:
Types de publication
Clinical Trial Protocol
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
587Subventions
Organisme : The Kavli Trust
ID : 32/18
Références
Lancet Psychiatry. 2017 Feb;4(2):109-119
pubmed: 27914903
PeerJ. 2013 Jul 09;1:e102
pubmed: 23862104
Psychother Psychosom. 2012;81(6):344-55
pubmed: 22964540
J Consult Clin Psychol. 2017 Feb;85(2):160-177
pubmed: 27775414
BMJ Open. 2012 Dec 19;2(6):
pubmed: 23257775
Cochrane Database Syst Rev. 2012 Nov 14;11:CD004851
pubmed: 23152227
Psychother Psychosom. 2018;87(4):223-233
pubmed: 29895001
Epidemiol Psychiatr Sci. 2016 Oct;25(5):428-435
pubmed: 26411384
BJPsych Open. 2018 Jul 25;4(4):307-312
pubmed: 30083384
JAMA Psychiatry. 2016 Sep 1;73(9):904-11
pubmed: 27487573
J Med Internet Res. 2019 Nov 1;21(11):e13393
pubmed: 31682572
Int J Methods Psychiatr Res. 2010 Dec;19(4):185-94
pubmed: 20683845
BJPsych Open. 2018 Jun 26;4(4):199-207
pubmed: 29988969
Depress Anxiety. 2016 Dec;33(12):1090-1098
pubmed: 27029912
J Med Internet Res. 2011 Dec 31;13(4):e126
pubmed: 22209829
BMC Psychiatry. 2011 Aug 12;11:131
pubmed: 21838902
BMJ Open. 2019 Mar 1;9(3):e024939
pubmed: 30826765
Arch Gen Psychiatry. 2004 Mar;61(3):310-7
pubmed: 14993119
PLoS One. 2018 Oct 3;13(10):e0205095
pubmed: 30281666
Psychother Res. 2003 Mar;13(1):59-76
pubmed: 22475163
J Am Acad Child Adolesc Psychiatry. 1998 Jan;37(1):26-34
pubmed: 9444896
Z Psychosom Med Psychother. 2015;61(3):262-74
pubmed: 26388057
Biol Psychiatry. 2003 Sep 1;54(5):573-83
pubmed: 12946886
J Med Internet Res. 2020 Mar 30;22(3):e18047
pubmed: 32224489
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Assessment. 2017 Jul;24(5):615-631
pubmed: 26676917
Am J Psychiatry. 2011 Dec;168(12):1266-77
pubmed: 22193671
J Consult Clin Psychol. 1991 Feb;59(1):12-9
pubmed: 2002127
Am J Psychiatry. 2013 Sep;170(9):1041-50
pubmed: 24030613
BMC Health Serv Res. 2013 Jun 15;13:217
pubmed: 23768141
J Am Acad Child Adolesc Psychiatry. 2013 Aug;52(8):863-75
pubmed: 23880496
JAMA. 2000 May 17;283(19):2529-36
pubmed: 10815116
Internet Interv. 2016 Oct 03;6:107-114
pubmed: 30135819
Drug Alcohol Depend. 2016 May 1;162:154-61
pubmed: 27006273
Attach Hum Dev. 2014;16(1):58-76
pubmed: 24215182
Biol Psychiatry. 2001 Jun 15;49(12):1091-100
pubmed: 11430851
Psychol Assess. 2015 Mar;27(1):169-83
pubmed: 25346997
JMIR Ment Health. 2017 Oct 16;4(4):e41
pubmed: 29038094
Clin Psychol Psychother. 2011 May-Jun;18(3):250-5
pubmed: 21584907
J Am Acad Child Adolesc Psychiatry. 2007 Apr;46(4):438-447
pubmed: 17420678
World Psychiatry. 2019 Feb;18(1):20-28
pubmed: 30600624
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):345-59
pubmed: 20633738
Psychol Med. 2012 Sep;42(9):1879-90
pubmed: 22153017
Clin Psychol Rev. 2016 Dec;50:1-10
pubmed: 27668988
Cogn Behav Ther. 2018 Jan;47(1):1-18
pubmed: 29215315
Psychotherapy (Chic). 2017 Dec;54(4):351-360
pubmed: 29251954
Control Clin Trials. 2002 Jun;23(3):257-73
pubmed: 12057878